,,Agreed a buy out is a clean way for a disposition here,,, however,,accessing the 2020 IPOs especially in biotech the Market Cap assigned by the backing entitiy averages about $300 Million,,possibly,,they look to be in that range,,,so our PP share price would be in line at the time imo,,,however once trading that MC can explode! I assume DMcC puts a value on Zen in the Billions as I type,,,,my point is the sale price might just increase due to market assessment and not be limited to the buy side in a BSA. I think the move to go public would increase this company'e value for any future sale and give us shareholders liquidity and those wanting in an opportuity to do so! Seems reasonable imo.